HEMEX Benelux

Vital Decosterstraat 16

3000 Leuven

BE

HEMEX Benelux

Foundation date

01/09/2023

Sector

#Biotechnology / R&D Services

Subsector

Therapeutic areas

HEMEX, a CRO, provides clinical development services for healthcare SMEs, covering phases from late pre-clinical to phases I-IV, CE-mark applications, and post-market clinical investigations. Our extensive track record encompasses diverse therapeutic areas, including pharmaceuticals, biotechnology, medical devices, IVDs, and digital health. Collaborating with universities, hospitals, professionals, patient groups, and corporations, we have excelled in clinical, regulatory, and quality projects.

Upcoming events

Latest news

  • V-Bio Ventures leads €20 million Series A financing of Precision oncology company Flindr Therapeutics to advance first-in-class small molecule inhibitors

    Wednesday April 24th 2024

  • Labconsort and NEKTARI join forces for a more sustainable and social industry

    Saturday April 20th 2024

  • BIO INX Complements Advisory Board with Distinguished Industry Leaders

    Thursday April 18th 2024